Qiangling L. Yin

Wuhan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Pre-pandemic contraction, phase-specific rate variation, and site-specific antigenic adaptation shape influenza A(H3N2) evolutionary dynamics in Hubei, China.

Pre-pandemic contraction, phase-specific rate variation, and site-specific antigenic adaptation shape influenza A(H3N2) evolutionary dynamics in Hubei, China.

Journal: Journal of virology

Published: June 10, 2026

The Discrepancy Between Influenza Vaccine Recommendation and Uptake Among Healthcare Workers in China: A Multicenter Cross-Sectional Study.

The Discrepancy Between Influenza Vaccine Recommendation and Uptake Among Healthcare Workers in China: A Multicenter Cross-Sectional Study.

Journal: Vaccines

Published: January 07, 2026

Reactive oxygen species-responsive virus-mimicking nanodrug for the treatment of influenza A virus infection.

Reactive oxygen species-responsive virus-mimicking nanodrug for the treatment of influenza A virus infection.

Journal: Colloids and surfaces. B, Biointerfaces

Published: May 21, 2025

Epidemiological characteristics of human respiratory syncytial virus in Hubei Province from 2016 to 2023

Epidemiological characteristics of human respiratory syncytial virus in Hubei Province from 2016 to 2023

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: August 14, 2024

Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China.

Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China.

Journal: Emerging microbes & infections

Published: November 16, 2023

Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages.

Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages.

Journal: Cell discovery

Published: May 25, 2022

Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants.

Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants.

Journal: Virologica Sinica

Published: January 23, 2022

Chemiluminescence Immunoassay Based Serological Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Vaccinated Population.

Chemiluminescence Immunoassay Based Serological Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Vaccinated Population.

Journal: Viruses

Published: June 22, 2021

Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.

Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.

Journal: Virologica Sinica

Published: March 16, 2021

Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients.

Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients.

Journal: Scientific reports

Published: September 30, 2020

Hemorrhagic Fever with Renal Syndrome - Liaoning Province, China, 1999-2018.

Hemorrhagic Fever with Renal Syndrome - Liaoning Province, China, 1999-2018.

Journal: China CDC weekly

Published: December 18, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026